Product Information
BIMATOPROST 0.03% EYE DROPS is a generic product labeled by Aurobindo Pharma Limited, priced at $6.9689 per ML under NDC 65862080244. Its NADAC has been published 156 times since Oct 11, 2023.
FDA first approved this application on Oct 6, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
.3 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862080244
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BIMATOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA205537FDA Approved
10/6/2022
TE Code
AT
On Market Since
10/6/2022
Pharmacological Classes
Price Statistics
The NADAC for BIMATOPROST 0.03% EYE DROPS has been published 156 times since Oct 11, 2023, and over the history we have for it it has declined 55.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9689 per ML |
|---|---|
| All-time high | $21.9729 (Dec 13, 2023) |
| All-time low | $6.9689 (Sep 23, 2026) |
| 52-week high | $12.8603 |
| 52-week low | $6.9689 |
| Median price | $12.8560 |
| Average price | $12.6584 |
| Largest weekly change | +33.9% (Aug 21, 2024) |
| Weeks tracked | 156 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bimatoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BIMATOPROST 0.03% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BIMATOPROST 0.03% EYE DROPS, manufactured by Aurobindo Pharma Limited, is $6.9689 per ML (NDC 65862080244), effective Sep 30, 2026.
How has the price of BIMATOPROST 0.03% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BIMATOPROST 0.03% EYE DROPS has declined 55.6%. It has been tracked across 156 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for BIMATOPROST 0.03% EYE DROPS?
Since Oct 11, 2023, the NADAC for BIMATOPROST 0.03% EYE DROPS has ranged from a low of $6.9689 (Sep 23, 2026) to a high of $21.9729 (Dec 13, 2023), with a median of $12.8560 per ML.
Are there cheaper alternatives to BIMATOPROST 0.03% EYE DROPS?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BIMATOPROST 0.03% EYE DROPS, is $4.2071 per ML — about 40% below BIMATOPROST 0.03% EYE DROPS.
Who manufactures BIMATOPROST 0.03% EYE DROPS?
BIMATOPROST 0.03% EYE DROPS (NDC 65862080244) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.